作者: Farhad Fakhrejahani , Yusuke Tomita , Agnes Maj-Hes , Jane B. Trepel , Maria De Santis
DOI: 10.1097/MOU.0000000000000213
关键词:
摘要: Purpose of reviewWe review recent data on immunotherapies for bladder cancer and discuss strategies to maximize the antitumor effect immunotherapy in solid tumors.Recent findingsAnti-programmed death ligand 1 has shown promise advanced cancer. Clinical trials immune checkpoint inhib